Study Findings from First Hospital of Lanzhou University Provide New Insights into Cholestasis (Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies)

Press/Media

Period4 Jul 2023

Media coverage

1

Media coverage

  • TitleStudy Findings from First Hospital of Lanzhou University Provide New Insights into Cholestasis (Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies)
    Media name/outletNewsRx Drug Daily
    Country/TerritoryUnited States
    Date4/07/23
    PersonsJINGJING GUO